GlycoMimetics Statistics Share Statistics GlycoMimetics has 64.53M
shares outstanding. The number of shares has increased by 0.07%
in one year.
Shares Outstanding 64.53M Shares Change (YoY) 0.07% Shares Change (QoQ) 0.03% Owned by Institutions (%) 47.68% Shares Floating 645.15K Failed to Deliver (FTD) Shares 212 FTD / Avg. Volume 1.07%
Short Selling Information The latest short interest is 6.11M, so 0% of the outstanding
shares have been sold short.
Short Interest 6.11M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -42.38 and the forward
PE ratio is -523.5.
GlycoMimetics's PEG ratio is
-24.58.
PE Ratio -42.38 Forward PE -523.5 PS Ratio 0 Forward PS 800.1 PB Ratio 0.3 P/FCF Ratio -51.61 PEG Ratio -24.58
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for GlycoMimetics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.92,
with a Debt / Equity ratio of 0.
Current Ratio 1.92 Quick Ratio 1.92 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-9.47M Employee Count 4 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -10.69% in the
last 52 weeks. The beta is 1.6, so GlycoMimetics's
price volatility has been higher than the market average.
Beta 1.6 52-Week Price Change -10.69% 50-Day Moving Average 21.19 200-Day Moving Average 24.46 Relative Strength Index (RSI) 39.5 Average Volume (20 Days) 19,728
Income Statement
Revenue n/a Gross Profit -35.17K Operating Income -32.51M Net Income -37.88M EBITDA -37.84M EBIT -37.88M Earnings Per Share (EPS) -0.59
Full Income Statement Balance Sheet The company has 10.72M in cash and 66.84K in
debt, giving a net cash position of 10.65M.
Cash & Cash Equivalents 10.72M Total Debt 66.84K Net Cash 10.65M Retained Earnings -494.36B Total Assets 157.43M Working Capital 137.48M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -31.1M
and capital expenditures -9.97K, giving a free cash flow of -31.11M.
Operating Cash Flow -31.1M Capital Expenditures -9.97K Free Cash Flow -31.11M FCF Per Share -0.48
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields GLYC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for GLYC.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 16, 2025. It was a
backward
split with a ratio of 1:100.
Last Split Date Jun 16, 2025 Split Type backward Split Ratio 1:100
Scores Altman Z-Score 33.29 Piotroski F-Score 2
